Belite Bio, Inc (BLTE)

Nasdaq · Healthcare · Biotechnology
$127.38-15.65%As of 2026-11-22 · USD
Last session low $120.00Last session high $135.06
52-week low $115.4152-week high $200.00
Market cap
$5.17B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)34.6In the neutral range (30 to 70)
MACD (12, 26, 9)-1.25Below its signal line (-0.08); histogram -1.17
Bollinger %B (20, 2)-33%Below the lower band (137.76 to 168.88)
SMA 20153.32Price is 16.9% below
SMA 50157.75Price is 19.3% below
SMA 200159.49Price is 20.1% below
ATR (20)6.78% of priceAverage true range per day
52-week position14%In the lower part of the 115.41 to 200.00 range

About Belite Bio, Inc

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States.

Insider filings, 90 daysNo purchases and 5 sales (about $32.0M).

More in Biotechnology